Sales Growth YoY (Last Twelve Months): Lexicon Corp (LXRX)

Graphic logo of Lexicon Pharmaceuticals (LXRX)

Lexicon Pharmaceuticals (LXRX) is focusing on the independent market launch of its cardiology drug while ignoring merger and acquisition deals. This TTM annual sales growth chart helps identify a demand reversal, where the -46.10 mark reflects the latest data. Success depends on Inpefa sales rates, insurance coverage, and costs, as well as physician confidence and the availability of subsidized quotas.

Sales Growth YoY (Last Twelve Months): Lexicon Pharma (LXRX) for 02/11/2024 - 11/18/2026

Summary analytical data breakdowns for Lexicon Pharmaceuticals, Inc. (LXRX)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Summary company analytics:Lexicon Pharmaceuticals
Mass-produced product of lexpharma.com

Lexicon Pharmaceuticals (LXRX) expansion into the commercial market through the growth of its sales representative workforce directly impacts drug sales dynamics. This indicator measures the percentage deviation of current trailing 12-month total revenue from the same period last year, allowing the historical trend of year-over-year 12-month revenue changes to identify operational slowdowns or business accelerations between quarterly reports.

Competitor analysis for Lexicon Pharmaceuticals

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|MoonLake Corp (MLTX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) crinetics.com (CRNX)|Revenue Growth YoY (Last 12 Months) newamsterdampharma.com NAMS|Sales Growth YoY (Last Twelve Months) Soleno Therapeutics Inc SLNO|Sales Growth YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) MiMedx Group, Inc.|Sales Growth YoY (Last Twelve Months) Rezolute Bio|Sales Growth YoY (Last Twelve Months) MBX|Sales Growth YoY (Last Twelve Months) Altimmune Pharma (ALT)|Sales Growth YoY (Last Twelve Months) AARD (Aardvark Therapeutics Corp)|Sales Growth YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Trailing Twelve Months Revenue Growth|BMEA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Revenue Growth YoY (Last 12 Months)|vTv Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Agape ATP Corp.|Revenue Growth YoY (Last 12 Months) Pluri (PLUR)|Sales Growth YoY (TTM) SYBX|Annual Revenue Growth (Last Twelve Months) Lipocine Inc|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)